| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0007 |